Provided by Tiger Trade Technology Pte. Ltd.

Aligos Therapeutics, Inc.

7.09
+0.15002.16%
Pre-market: 6.90-0.1900-2.68%07:29 EST
Volume:20.09K
Turnover:141.95K
Market Cap:43.63M
PE:-0.52
High:7.25
Open:7.00
Low:6.85
Close:6.94
52wk High:18.75
52wk Low:3.76
Shares:6.15M
Float Shares:3.00M
Volume Ratio:0.68
T/O Rate:0.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.5400
EPS(LYR):-20.9448
ROE:-141.82%
ROA:-54.70%
PB:0.61
PE(LYR):-0.34

Loading ...

Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2023

Major Issues Report

Form 8-K - Current report
Jul 25, 2023

Major Issues Report

Form 8-K - Current report
May 04, 2023

Major Issues Report

8-K - Current report
May 04, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 09, 2023

Major Issues Report

8-K - Current report
Mar 09, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 27, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 22, 2022

Correspondence

CORRESP [Cover] - Correspondence
Nov 02, 2022

Major Issues Report

8-K - Current report
Nov 02, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 27, 2022

Major Issues Report

8-K - Current report